Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01842009 · ClinicalTrials.gov registry record · NA
Single-arm, Open-label, Phase II Trial of HD-tDCS in Fibromyalgia Patients
A NA study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01842009 is a NA study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 20 participants.
The verdict
NCT01842009, a NA study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the mean number of stimulation (high definition-transcranial direct current stimulation) sessions (up to 26) needed to achieve a clinical response with this response defined as a 50% decrease in Visual Analog Scale (VAS) for pain. These data will be important in defining the optimal number of sessions for future fibromyalgia subjects in Phase III trials.
Interventions
- DEVICE High Definition transcranial Direct Current Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01842009
The ClinicalTrials.gov registry entry for NCT01842009 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spaulding Rehabilitation Hospital, which has 101 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High Definition transcranial Direct Current Stimulation is the first listed.
NCT01842009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01842009 about?
NCT01842009 is a clinical study titled "Single-arm, Open-label, Phase II Trial of HD-tDCS in Fibromyalgia Patients". The purpose of this study is to investigate the mean number of stimulation (high definition-transcranial direct current stimulation) sessions (up to 26) needed to achieve a clinical response with this response defined as a 50% decrease in Visual Analog Scale (VAS) for pain. These data will be import...
What is the current status of trial NCT01842009?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-03. Estimated completion is 2016-06-07.
What interventions are being tested in trial NCT01842009?
The interventions under investigation include: High Definition transcranial Direct Current Stimulation (DEVICE).
Who is sponsoring clinical trial NCT01842009?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.